FMR CORP 13D and 13G filings for Sagimet Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-11 08:19 am Sale |
2024-03-08 | 13G | Sagimet Biosciences Inc. SGMT |
FMR CORP | 742,392 2.444% |
-1,179,664 (-61.38%) |
Filing |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Sagimet Biosciences Inc. SGMT |
FMR CORP | 1,922,056 8.991% |
-708,104 (-26.92%) |
Filing |
| 2023-09-11 08:23 am Purchase |
2023-09-08 | 13G | Sagimet Biosciences Inc. SGMT |
FMR CORP | 2,630,160 12.316% |
2,630,160 (New Position) |
Filing |